CSF1 and angina pectoris: Being consistent with that, Rallidis LS’ research showed that high M-CSF is an independent predictor of adverse events in hospitalized patients [14] and the high level of M-CSF at the end of 6-week follow-up is a strongly predictor of long-term adverse outcome in patients with serious unstable angina [15].